| Literature DB >> 35161136 |
Stefania Dinu1,2, Emanuela Lidia Craciunescu3,4, Ioana Macasoi5,6, Doina Chioran7, Mircea Rivis8, Daliborca Vlad9, Raluca Adriana Milutinovici10,11, Iasmina Marcovici5,6, Alina Dolghi5,6, Alina Moaca5,6, Dorin Cristian Dinu12, Cristina Dehelean5,6, Malina Popa1,2.
Abstract
Malocclusion is a global health problem, mainly affecting children and adolescents. For this reason, orthodontic treatment must be, on the one hand, safe, non-toxic, and effective and, on the other hand, it must have the best possible esthetic profile. Thus, the use of orthodontic appliances is addressed to all age groups, including young children, for a long period of time, which is why their safety profile is a matter of real interest. For this reason, the purpose of the present study was to evaluate the safety and biocompatibility of an acrylic removable orthodontic appliance made of polymethylmethacrylate and stainless steel alloy made by our team of researchers. To verify the biocompatibility of the medical device, it was immersed in artificial saliva with three different pHs (3, 7, and 10) for a period of ten days. Subsequently, the three types of saliva were tested on human keratinocytes (HaCaT cell line) in terms of viability and modification of cell morphology. Finally, the use of 3D reconstructed human epidermis verified the cytotoxic and irritating potential of the medical device, thus providing relevant information regarding its biocompatibility. The results revealed that by maintaining the orthodontic device in the saliva there is no release of substances with a toxic effect on the human keratinocytes and on the 3D reconstructed human epidermis. There were also no significant changes in cell morphology. In conclusion, it is suggested that the acrylic removable appliance has a safety profile recommended for in vivo use.Entities:
Keywords: 3D reconstructed human epidermis; acrylic removable appliance; biocompatibility; cytotoxicity; in vitro; orthodontics
Year: 2022 PMID: 35161136 PMCID: PMC8838812 DOI: 10.3390/ma15031193
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1Digital scans of the maxillary and mandibular arches and the bite registration.
Figure 2Intraoral scanner MEDIT i700 (Family Dental Clinic).
Figure 3Picture of the acrylic removable appliance (ARA) made by Docs Lab from Timisoara.
Figure 4In vitro evaluation of the effect exerted by DM suspended in (A) acidic saliva (pH = 3), (B) neutral saliva (pH = 7), and (C) basic saliva (pH = 10) on the viability of human keratinocytes - HaCaT cells following a 24 h treatment by performing the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Five different dilutions were tested (1:16, 1:8, 1:4, 1:2, 1:1). Data are presented as viability percentages (%) normalized to control and expressed as mean values ± SD of three independent experiments performed in triplicate. The statistical differences between the control and the treated group were verified by applying the one-way ANOVA analysis followed by Dunett’s multiple comparisons post-test (* p < 0.1).
Figure 5In vitro evaluation of the effect exerted by DM suspended in (A) acidic saliva (pH = 3), (B) neutral saliva (pH = 7), and (C) basic saliva (pH = 10) on the viability of HaCaT cells following a 72 h treatment by performing the MTT assay. Five different dilutions were tested (1:16, 1:8, 1:4, 1:2, 1:1). Data are presented as viability percentages (%) normalized to control and expressed as mean values ± SD of three independent experiments performed in triplicate. The statistical differences between the control and the treated group were verified by applying the one-way ANOVA analysis followed by Dunett’s multiple comparisons post-test (* p < 0.1, ** p < 0.01, and **** p < 0.0001).
Figure 6Morphology and confluence of HaCaT cells following the 24 h stimulation with ARA suspended in acidic, neutral, and basic artificial saliva. The highest (1:16) and the lowest (1:1) dilutions were selected for this evaluation. The scale bars represent 100 µm.
Figure 7Viability percentage of EpiDerm skin model inserts (EPI-200 SIT) at 18 h post-treatment with the test sample (ARAa, ARAn, and ARAb) at the dilution of 1:1. One-way ANOVA analysis and Dunett’s post-test were performed to determine the statistical differences between sample-treated inserts and negative control-treated inserts (** p < 0.01; **** p < 0.0001). Positive control (PC) is 1% SDS, while the negative control (NC) is DPBS.